Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

5274 ARTÍCULOS , VIENDO DEL 1636 AL 1650

Pharmacotherapy and the Role of Pharmacists in Rehabilitation Medicine

Yoshimura Y, Matsumoto A, Momosaki R.

Prog Rehabil Med. 2022 May 14;7:20220025. doi: 10.2490/prm.20220025. eCollection 2022.

Metabolic Diffusion in Neuropathologies: The Relevance of Brain-Liver Axis

Vegas-Suárez S, Simón J, Martínez-Chantar ML, Moratalla R.

Front Physiol. 2022 May 12;13:864263. doi: 10.3389/fphys.2022.864263. eCollection 2022.

Cognitive Impact of Deep Brain Stimulation in Parkinson's Disease Patients: A Systematic Review

Rački V, Hero M, Rožmarić G, Papić E, Raguž M, Chudy D, Vuletić V.

Front Hum Neurosci. 2022 May 13;16:867055. doi: 10.3389/fnhum.2022.867055. eCollection 2022.

Research progress on the protective effects of aucubin in neurological diseases

Yang P, Zhang Q, Shen H, Bai X, Liu P, Zhang T.

Pharm Biol. 2022 Dec;60(1):1088-1094. doi: 10.1080/13880209.2022.2074057.

The Unbearable Lightness of Brundin

Bloem BR, Kordower JH.

J Parkinsons Dis. 2022;12(4):1069-1072. doi: 10.3233/JPD-229003.

Bromocriptine therapy: Review of mechanism of action, safety and tolerability

Naz F, Malik A, Riaz M, Mahmood Q, Mehmood MH, Rasool G, Mahmood Z, Abbas M.

Clin Exp Pharmacol Physiol. 2022 Aug;49(8):903-922. doi: 10.1111/1440-1681.13678. Epub 2022 Jun 22.

[Apomorphine and frontal dysfunction in Parkinson's disease]

Fernández-Pajarín G, Martín-Jiménez I, Ares-Pensado B, Sesar-Ignacio A.

Rev Neurol. 2022 Jun 1;74(11):367-371. doi: 10.33588/rn.7411.2022080.

Evaluation of curcumin as add-on therapy in patients with Parkinson's disease: A pilot randomized, triple-blind, placebo-controlled trial

Ghodsi H, Rahimi HR, Aghili SM, Saberi A, Shoeibi A.

Clin Neurol Neurosurg. 2022 Jul;218:107300. doi: 10.1016/j.clineuro.2022.107300. Epub 2022 May 18.

Applications of Gold Nanoparticles in Brain Diseases across the Blood-Brain Barrier

Zhang J, Yang T, Huang W, Yu Y, Sun T.

Curr Med Chem. 2022;29(39):6063-6083. doi: 10.2174/0929867329666220527121943.

Modulation of cellular redox environment as a novel therapeutic strategy for Parkinson's disease

Deus CM, Teixeira J, Raimundo N, Tucci P, Borges F, Saso L, Oliveira PJ.

Eur J Clin Invest. 2022 Oct;52(10):e13820. doi: 10.1111/eci.13820. Epub 2022 Jun 13.

GBA-associated PD: chances and obstacles for targeted treatment strategies

Höglinger G, Schulte C, Jost WH, Storch A, Woitalla D, Krüger R, Falkenburger B, Brockmann K.

J Neural Transm (Vienna). 2022 Sep;129(9):1219-1233. doi: 10.1007/s00702-022-02511-7. Epub 2022 May 31.

Novel insights into the role of circular RNAs in Parkinson disease: An emerging renaissance in the management of neurodegenerative diseases

Dorostgou Z, Yadegar N, Dorostgou Z, Khorvash F, Vakili O.

J Neurosci Res. 2022 Sep;100(9):1775-1790. doi: 10.1002/jnr.25094. Epub 2022 May 31.

Leucine-rich repeat kinase 2 (LRRK2): an update on the potential therapeutic target for Parkinson's disease

Kluss JH, Lewis PA, Greggio E.

Expert Opin Ther Targets. 2022 Jun;26(6):537-546. doi: 10.1080/14728222.2022.2082937. Epub 2022 Jun 2.

Effect of mobile health intervention for self-management on self-efficacy, motor and non-motor symptoms, self-management, and quality of life in people with Parkinson's disease: Randomized controlled trial

Park Y, Kim SR, So HY, Jo S, Lee SH, Hwang YS, Kim MS, Chung SJ.

Geriatr Nurs. 2022 Jul-Aug;46:90-97. doi: 10.1016/j.gerinurse.2022.05.003. Epub 2022 May 26.

Skin alpha-synuclein deposit patterns: A predictor of Parkinson's disease subtypes

Han Y, Wu D, Wang Y, Xie J, Zhang Z.

EBioMedicine. 2022 Jun;80:104076. doi: 10.1016/j.ebiom.2022.104076. Epub 2022 May 26.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias